ArticleJournal of medical case reports2025
Possible shared pathogenesis between idiopathic sensory ganglionopathy and achalasia: a case report.
Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIdiopathic sensory ganglionopathy is characterized by dorsal root ganglion dysfunction, while achalasia is an esophageal motility disorder marked by impaired relaxation of the lower esophageal sphincter. Although both may have immune-mediated components, their concurrent presentation without other autoimmune comorbidities is exceedingly rare. CASE PRESENTATION: We describe a 44-year-old Thai male who presented with progressive sensory disturbances and dysphagia. Neurological evaluations confirmed idiopathic sensory ganglionopathy, while esophageal manometry identified achalasia type II. The patient initially received high-dose steroids but developed steroid-induced Cushing syndrome, prompting a switch to intravenous immunoglobulin therapy, which improved the sensory symptoms but did not alleviate the dysphagia. Ultimately, pneumatic dilation fully resolved his achalasia-related swallowing difficulties.
conclusionThis case underscores a possible overlapping autoimmune pathogenesis for idiopathic sensory ganglionopathy and achalasia, even in the absence of other known autoimmune disorders. The contrasting responses to immunotherapy highlight the complexity of treating coexisting conditions with distinct disease mechanisms. Further research into shared immunologic pathways may advance our understanding of these rare but notable disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.